AI-generated summary
In this double-blind, placebo-controlled trial, the authors studied residents of a Pennsylvania long term care facility who received either blue light or dim red light for 30 minutes on weekdays over 4 weeks. The authors report that three cognitive composite scores and one mood measure differed significantly between groups, favoring blue light. They describe blue light as a possibly promising intervention, but the sample was small.
- Who or what was studied
- Residents of a long term care facility in Pennsylvania receiving personal care or skilled nursing care (15 treatment, 13 placebo)
- Limits stated in the abstract
- The abstract describes a small sample of 28 residents from a single facility, and its conclusion is framed as promising rather than definitive.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Lux, Light-emitting diode, Placebo-controlled, Placebo effect, Anxiety. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.